Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,760 | -14,658 | -10,785 | -5,080 | -3,442 |
| Depreciation Amortization | 273 | 480 | 473 | 131 | 16 |
| Accounts receivable | N/A | 2 | -352 | -140 | -1 |
| Accounts payable and accrued liabilities | 301 | 265 | -59 | 4 | 65 |
| Other Working Capital | 326 | 320 | -803 | 898 | -298 |
| Other Operating Activity | 907 | 3,036 | 2,696 | 289 | 169 |
| Operating Cash Flow | $-13,953 | $-10,556 | $-8,830 | $-3,900 | $-3,492 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -131 | 159 | -244 | -135 | -137 |
| Purchase Sale Intangibles | N/A | -164 | -245 | N/A | N/A |
| Other Investing Activity | -158 | -502 | -245 | 0 | 0 |
| Investing Cash Flow | $-288 | $-343 | $-490 | $-135 | $-137 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 1,000 | 0 |
| Debt Repayment | N/A | -99 | N/A | -1,005 | -184 |
| Common Stock Issued | 9,457 | 13,156 | 13,937 | 3,854 | 5,714 |
| Financing Cash Flow | $9,457 | $13,057 | $13,937 | $3,849 | $5,530 |
| Beginning Cash Position | 8,501 | 6,342 | 1,725 | 1,911 | 10 |
| End Cash Position | 3,716 | 8,501 | 6,342 | 1,725 | 1,911 |
| Net Cash Flow | $-4,785 | $2,159 | $4,617 | $-186 | $1,901 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,953 | -10,556 | -8,830 | -3,900 | -3,492 |
| Capital Expenditure | -131 | 159 | -244 | -135 | -137 |
| Free Cash Flow | -14,084 | -10,397 | -9,074 | -4,035 | -3,629 |